US Patent 11679087 Use of cannabinoids in the treatment of Angelman syndrome
All edits
Edits on 2 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 21 Jun, 2023
Golden AI
Edits made to:
Infobox (+25 properties)
Article (+294 characters)
US Patent 11679087 Use of cannabinoids in the treatment of Angelman syndrome
Article
The present invention relates to the use of cannabidiol (CBD) in the treatment of Angelman syndrome (AS). CBD has been shown to be particularly effective in improving anxiety in rodent models of AS. The CBD is preferably substantially pure. It may take the form of a highly purified extract of
Infobox
Is a
Patent Jurisdiction
Patent Number
116790870
Date of Patent
June 20, 2023
0Patent Application Number
164676390
Date Filed
December 13, 2017
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11679087 Use of cannabinoids in the treatment of Angelman syndrome
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
